Fosters Research
No Result
View All Result
No Result
View All Result
Fosters Research
No Result
View All Result
Home Industry

An overview of HealthEquity Inc.’s (HQY) institutional holdings

January 13, 2023
in Industry

In yesterday’s Wall Street session, HealthEquity Inc. (NASDAQ:HQY) shares traded at $58.42, up 3.02% from the previous session.

12 analysts cover HealthEquity Inc. (NASDAQ:HQY), according to research data. The consensus rating among analysts is ‘Buy’. As we calculate the median target price by taking the range between a high of $101.00 and a low of $75.00, we find $84.50. Given the previous closing price of $56.71, this indicates a potential upside of 49.0 percent. HQY stock price is now -9.27% away from the 50-day moving average and -9.69% away from the 200-day moving average. The market capitalization of the company currently stands at $4.99B.

Will You Miss Out On This Growth Stock Boom?

A new megatrend in the fintech market is well underway. Mobile payments are projected to boom into a massive $12 trillion market by 2028. According to Motley Fool this growth stock could "deliver huge returns." Not only in the immediate future but also over the next decade. Especially since the man behind this company is a serial entrepreneur who has been wildly successful over the years.

And this is just one of our 5 Best Growth Stocks To Own For 2023.

Sponsored

The stock has received a hold rating from 1 analysts and a buy rating from 10. Brokers who have rated the stock have averaged $84.08 as their price target over the next twelve months.

With the price target enhanced from $64 to $77, Goldman Upgraded its rating from Sell to Neutral for HealthEquity Inc. (NASDAQ: HQY). On September 16, 2022, KeyBanc Capital Markets recently initiated its ‘Overweight’ rating on the stock quoting a target price of $85, while ‘Goldman’ rates the stock as ‘Sell’.

In other news, Wellborn Gayle Furgurson, Director sold 5,237 shares of the company’s stock on Dec 14. The stock was sold for $324,694 at an average price of $62.00. Upon completion of the transaction, the Director now directly owns 12,023 shares in the company, valued at $0.7 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Oct 21, EVP, GC & CORPORATE SECRETARY Ladd Delano sold 5,897 shares of the business’s stock. A total of $442,275 was realized by selling the stock at an average price of $75.00. This leaves the insider owning 37,471 shares of the company worth $2.19 million. Insiders disposed of 106,350 shares of company stock worth roughly $6.21 million over the past 1 year. A total of 0.50% of the company’s stock is owned by insiders.

There have been several recent changes in the stakes of large investors in HQY stock. A new stake in HealthEquity Inc. shares was purchased by LORD, ABBETT & CO. LLC during the first quarter worth $43,646,000. AGF INVESTMENTS INC. invested $9,347,000 in shares of HQY during the first quarter. In the first quarter, MOODY ALDRICH PARTNERS LLC acquired a new stake in HealthEquity Inc. valued at approximately $4,395,000. AMALGAMATED FINANCIAL CORP. acquired a new stake in HQY for approximately $3,302,000. GREAT WEST LIFE ASSURANCE CO /CAN/ purchased a new stake in HQY valued at around $3,272,000 in the second quarter.

On Thursday morning HealthEquity Inc. (NASDAQ: HQY) stock kicked off with the opening price of $56.54. During the past 12 months, HealthEquity Inc. has had a low of $47.77 and a high of $79.20. As of last week, the company has a debt-to-equity ratio of 0.49, a current ratio of 3.00, and a quick ratio of 3.00. The fifty day moving average price for HQY is $64.39 and a two-hundred day moving average price translates $64.69 for the stock.

The latest earnings results from HealthEquity Inc. (NASDAQ: HQY) was released for Jul, 2022. According to the Health Information Services Company, earnings per share came in at $0.33, inline with analysts’ expectations of $0.33. This compares to -$0.06 EPS in the same period last year. The net profit margin was -7.10% and return on equity was -3.20% for HQY. The company reported revenue of $216.09 million for the quarter, compared to $179.95 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 20.08 percent. For the current quarter, analysts expect HQY to generate $206.76M in revenue.

HealthEquity Inc.(HQY) Company Profile

HealthEquity, Inc. provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, compare treatment options and prices, receive personalized benefit and clinical information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts. It also provides mutual fund investment platform; and online-only automated investment advisory services through Advisor, a Web-based tool. In addition, the company offers flexible spending accounts; health reimbursement arrangements; and Consolidated Omnibus Budget Reconciliation Act continuation services, as well as administers pre-tax commuter benefit programs. It serves clients through a direct sales force; benefits brokers and advisors; and a network of health plans, benefits administrators, benefits brokers and consultants, and retirement plan record-keepers. The company was incorporated in 2002 and is headquartered in Draper, Utah.

Tags: HealthEquity Inc.HQYHQY stockNASDAQ:HQY

Related Posts

Can Titan Pharmaceuticals Inc. (TTNP) stock recover despite sales dropping?

January 27, 2023

Investor Insight: OneWater Marine Inc. (ONEW) Goes Ballistic – Investor Confidence on the Rise

January 27, 2023

When is the right time to cash out of Matthews International Corporation [MATW] stock?

January 27, 2023

Is Atreca Inc. [BCEL] a good investment? Don’t be fooled by its recent momentum

January 27, 2023

The most important numbers to know about Ascent Solar Technologies Inc. (NASDAQ:ASTI)

January 27, 2023

Before You Invest In Harte Hanks Inc. (NASDAQ:HHS), Consider This Metric

January 27, 2023
Next Post

Do you still think Navient Corporation (NASDAQ:NAVI) is worth a look?

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended

Do you still think Brookfield Infrastructure Corporation (NYSE:BIPC) is worth a look?

4 months ago

Does Fastly Inc. (NYSE:FSLY) have deteriorating prospects?

2 months ago

A Stock With Stellar Fundamentals? Ares Commercial Real Estate Corporation (NYSE:ACRE): Is It Right For You?

4 weeks ago

A breakdown of the latest mutual funds holding Southwest Gas Holdings Inc. (SWX)

4 months ago
logo

Welcome to Fosters Research.
We provide quality information for free in a convenient place and format. You do not need to look for us – the news portal “Fosters Research” meets the reader every morning.

Categories

  • Analyst Opinions
  • Featured
  • Finance
  • Market News
  • Technical Indicators
  • Trending Stocks

Company

  • Home
  • About us
  • Contact

Recent Posts

  • Can Titan Pharmaceuticals Inc. (TTNP) stock recover despite sales dropping?
  • There is little time left for S&T Bancorp Inc. (STBA) to reach its 1-year target estimate. How soon will it surpass it?

Copyright © 2022 fostersresearch

No Result
View All Result
  • Home
  • Analyst Opinions
  • Market News
  • Technical Indicators
  • Trending Stocks

Copyright © 2022 fostersresearch